Carisma Therapeutics (CARM) Insider Trading & Ownership $0.04 +0.00 (+3.99%) As of 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Carisma Therapeutics (NASDAQ:CARM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$138.18K Get CARM Insider Trade Alerts Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CARM Insider Buying and Selling by Quarter Carisma Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/7/2025Michael KlichinskyInsiderSell56,982$0.25$14,245.50 10/3/2025Michael KlichinskyInsiderSell119,347$0.26$31,030.22 10/2/2025Michael KlichinskyInsiderSell200,000$0.25$50,000.00 10/1/2025Michael KlichinskyInsiderSell165,000$0.26$42,900.00 (Data available from 1/1/2013 forward) CARM Insider Trading Activity - Frequently Asked Questions Who is on Carisma Therapeutics' Insider Roster? The list of insiders at Carisma Therapeutics includes Michael Klichinsky. Learn more on insiders at CARM. What percentage of Carisma Therapeutics stock is owned by insiders? 6.90% of Carisma Therapeutics stock is owned by insiders. Learn more on CARM's insider holdings. Which Carisma Therapeutics insiders have been selling company stock? The following insider sold CARM shares in the last 24 months: Michael Klichinsky ($138,175.72). How much insider selling is happening at Carisma Therapeutics? Insiders have sold a total of 541,329 Carisma Therapeutics shares in the last 24 months for a total of $138,175.72 sold. Which members of congress are trading Carisma Therapeutics? Ro Khanna (D-CA) has sold shares of Carisma Therapeutics in the last year totaling $8,000. Carisma Therapeutics Key ExecutivesMr. Steven Kelly (Age 59)President, CEO & Director Compensation: $786.91kMr. Michael Klichinsky Ph.D. (Age 34)Pharm.D., PharmD, Co-Founder & Chief Scientific Officer Compensation: $525.43k4 recent tradesMr. Richard S. Morris CPA (Age 50)CFO, Chief Compliance Officer, Treasurer, Prin. Financial Off. & Prin. Acc. Off. Compensation: $584.85kDr. Saar Gill M.D.Ph.D., Co-Founder & Chairman of Scientific Advisory BoardMr. Eric H. Siegel J.D. (Age 59)MBA, General Counsel & Corporate Secretary Ms. Terry ShieldsSenior Vice President of Human ResourcesMr. Tom Wilton (Age 50)Chief Business Officer Dr. Eugene P. Kennedy F.A.C.S. (Age 55)M.D., Chief Medical Officer Mr. Kenneth LockeSenior Vice President of Technical Operations More Insider Trading Tools from MarketBeat Related Companies MIRA Pharmaceuticals Insider Selling Moleculin Biotech Insider Selling Aytu BioPharma Insider Selling AlloVir Insider Selling Cingulate Insider Selling Lixte Biotechnology Insider Selling Rallybio Insider Selling Synergy CHC Insider Selling Hoth Therapeutics Insider Selling Clearside Biomedical Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles WesBanco Insiders Signal Confidence With Coordinated BuysBig Insider Sales at NVDA, DELL, TMUS Raise Questions—Or Do They?3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's Comeback This page (NASDAQ:CARM) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CARM Stock Alerts